Trinity Biotech | TRIB - Sales Revenues


Trinity Biotech reported $14.31M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Abbott USD 11.16B 300M Mar/2026
Bayer EUR 11.44B 1.78B Dec/2025
Bio-Rad Laboratories USD 693.2M 40.2M Dec/2025
EDAP TMS EUR 13.88M 2.16M Sep/2025
J&J USD 24.1B 500M Mar/2026
Mesa Laboratories USD 62.84M 5.01M Dec/2024
OraSure Technologies USD 26.76M 322K Dec/2025
Plus Therapeutics USD 1.37M 30K Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Siemens EUR 19.14B 2.29B Dec/2025
Surmodics USD 29.57M 355K Jun/2025
Thermo Fisher Scientific USD 11.01B 1.2B Mar/2026
Tosoh JPY 256.94B 2.93B Dec/2025
Trinity Biotech USD 14.31M 1.55M Sep/2025
Veracyte USD 140.6M 8.7M Dec/2025